BELSYNC Trademark

Trademark Overview

On Wednesday, January 21, 2015, a trademark application was filed for BELSYNC with the United States Patent and Trademark Office. The USPTO has given the BELSYNC trademark a serial number of 86510049. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 3, 2018. This trademark is owned by Glaxo Group Limited. The BELSYNC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
belsync

General Information

Serial Number86510049
Word MarkBELSYNC
Filing DateWednesday, January 21, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 3, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 2, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, September 4, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 3, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2017EXTENSION 5 GRANTED
Friday, November 10, 2017EXTENSION 5 FILED
Friday, November 10, 2017TEAS EXTENSION RECEIVED
Thursday, July 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2017EXTENSION 4 GRANTED
Tuesday, July 11, 2017EXTENSION 4 FILED
Tuesday, July 11, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 10, 2016EXTENSION 3 GRANTED
Tuesday, December 6, 2016EXTENSION 3 FILED
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Thursday, August 25, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2016EXTENSION 2 GRANTED
Tuesday, July 26, 2016EXTENSION 2 FILED
Monday, August 22, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 26, 2016TEAS EXTENSION RECEIVED
Wednesday, December 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2015EXTENSION 1 GRANTED
Monday, December 21, 2015EXTENSION 1 FILED
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Tuesday, July 28, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 24, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 24, 2015ASSIGNED TO EXAMINER
Monday, February 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 24, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

belsync pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological